Re-irradiation After Osteocutaneous Free Flap Reconstruction for Locally Recurrent Head and Neck Cancer: A Case Series

S. Gondi,K. Reichl,P. Tassone
DOI: https://doi.org/10.1016/j.ijrobp.2024.01.088
IF: 8.013
2024-04-01
International Journal of Radiation Oncology*Biology*Physics
Abstract:Purpose/Objective(s) Recurrent head and neck cancer (HNC) poses difficult management. Salvage surgery is often used in these situations. However, even after salvage surgery, many patients are still considered high-risk for further recurrence and benefit from re-irradiation. Free flaps not only enable reconstruction following salvage surgery, but there have also been limited studies suggesting free flap reconstruction may reduce the amount of re-irradiation complications. There are no studies to date specifically examining the effects of osteocutaneous free flap reconstruction upon re-irradiation toxicity. We hypothesize that the rate of local adverse events after re-irradiation is low in the setting of bony free flap reconstruction. Materials/Methods Patients with recurrent HNC that received salvage surgery with osteocutaneous flaps were identified. Those who had a history of HNC radiation prior to salvage surgery and then underwent adjuvant re-irradiation were included. Descriptive statistics was performed to assess outcomes. Results Six HNC patients met criteria for inclusion. The type of flap was fibula in five and osteocutaneous radial forearm in one. Within 90 days of re-irradiation, three (50%) had radiation ulcers and one (16.6%) had mucositis. No patients had xerostomia, dermatitis, new dysphagia, or thrush as acute radiation toxicities. 90 days after re-irradiation, no additional patients had these symptoms suggesting there were no chronic radiation toxicities. Wounds present following re-irradiation included plate exposure greater than 6 months after re-irradiation in one (16.6%) and surgical site infection greater than 6 months after surgery in one (16.6%). No patients had osteoradionecrosis following re-irradiation, fistula, plate removal, or plate fracture. Diet at 12 months post op was PO in two (33.3%), partial PEG-dependence in two (33.3%), and complete PEG-dependence in two (33.3%). Trach at 12 months post op was present in two (33.3%) patients. 4 (66%) had HNC recurrence median overall survival of 34.4 months. Conclusion In this cohort of patients undergoing re-irradiation after bone free flap reconstruction, most patients avoided local adverse events related to re-irradiation.
oncology,radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?